Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

PBS. 2022; 12(1): 26-31


Distress Tolerance Levels and its Relation with Clinical Parameters in Psoriasis Disease

Mehmet Gurkan Gurok, Nese Gocer Gurok, Betul Demir, Murad Atmaca.




Abstract

Background: Psoriasis is a chronic inflammatory disorder with squamous erythematous lesions where genetic predisposition, trauma, infections, drugs, smoking and psychologic factors may play a role in its etiology. Objective: In this study we aimed to elaborate the stress tolerance levels of the patients with respect to clinical parameters. The findings of this research could drive physicians treatment attributes to enhance the importance of psychological streamline of the individual and the severity of the disease. Methods: A total of 45 psoriasis patients without any disease have been erolled in the study. The control group consisted of 45 healthy volunteers with similar baseline demographics but no physical or psychiatric disease. Both of the groups were evaluated with Psoriasis Severity Index (PASI), Socio-demographic and Clinical Data Form, Distress Tolerance Scale (DTS), Beck Depression Inventory, State and Trait Anxiety Inventory. Results: Both the patients and the control group had similar baseline demographics. Distress Tolerance Scale and its subgroup analysis showed statisticaly significant outcomes. DTS total scores (p

Key words: Psoriasis, Stress Tolerance, Depression, Anxiety






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.